Skip to main content

Steakholder Foods

HardwareRehovot, IsraelFounded 2019· One of 1818 Hardware companies tracked by AMPulse

Pioneer in 3D-printed cultivated meat technology, developing sustainable protein alternatives using proprietary 3D bioprinting and bioink systems for plant-based and cell-based structured meat products.

CEO / Founder
Arik Kaufman
Team Size
11-50
Stage
Active
Total Funding
$67.66M
Latest Round
Strategic Investment
Key Investors
Psagot Provident and Pension Funds; Mor investment house; Armistice Capital LLC; Alumni Capital LP

Technology & Products

Key Products

3D-printed cultivated meat, plant-based seafood, and Perfecta™ premium plant-based whole-cut meat products (steak, chicken breast) plus extruded products (salmon, white fish, hamburger patties); Perfecta launched in the US market in 2026 via KeHE Distributors.

Technological Advantage

Patented technologies for physical manipulation of cultured muscle tissue and bioprinting processes; scalable B2B model to accelerate market entry. Verified by producing the world's largest 3D-printed cultivated steak (104 grams).

Differentiation

Value Proposition

Provides a sustainable, slaughter-free, and scalable solution for producing high-quality, structured meat products that mimic the taste and texture of conventional meat.

How They Differentiate

Focus on 3D printing of whole-cut style meats and a B2B technology-provider model.

Market & Competition

Target Customers

Food manufacturers, alternative protein companies, and traditional meat producers.

Industry Verticals

Food Technology, Alternative Proteins, Food Manufacturing

Competitors

Beyond Meat, Mosa Meat, Upside Foods

Growth & Milestones

Growth Metrics

2024: Achieved first revenue, cut losses by 45%. Feb 2025: Secured $1.25M through securities purchase agreement. Established $8M equity line of credit through June 2026. Jun 2025: Gefen Capital-led $1.74M strategic investment tied to proposed Twine Solutions acquisition. Sep 2025: Warrant exercise for $1.5M with potential $4.5M additional. May 2026: Warrant exercise for $1.1M gross proceeds. Jul 2026: Launched Perfecta Premium Plant-Based Meat in US market. Jul 2026: 1-for-3 stock split effective. Nasdaq listed (STKH).

Major Milestones

Add: "2026 Jul: Launched Perfecta™ Premium Plant-Based Meat in the US market via KeHE Distributors (Northeastern US rollout, phased national expansion)"

Notable Customers

Wyler Farm (ordered SH™ - Beef premix blends for plant-based products)

https://steakholderfoods.com

Recent coverage of Steakholder Foods

Why this company matters

AMPulse analysis, not a company disclosure

Steakholder Foods positions itself as a B2B technology provider in the alternative protein space, differentiating from consumer-facing brands by licensing its 3D bioprinting and bioink systems to food manufacturers and traditional meat producers. The company targets the gap between unstructured plant-based patties and whole-cut meats, aiming to replicate the texture and mouthfeel of conventional muscle tissue through additive manufacturing.

The core technology centers on material extrusion-based bioprinting (MEX) using proprietary bioinks that combine cultivated cells or plant-based proteins. This approach allows for the physical manipulation of cultured muscle tissue into structured cuts, demonstrated by the production of a 104-gram 3D-printed cultivated steak in 2021. The company's product line includes SH™ Beef premix blends for plant-based products, sold to partners like Wyler Farm, and plant-based seafood alternatives.

Steakholder Foods targets food manufacturers, alternative protein companies, and traditional meat producers seeking to enter the structured meat segment without building in-house bioprinting capabilities. Key partnerships include UMAMI Bioworks for cell-based seafood, ENOUGH for mycoprotein integration, and a memorandum of understanding with Taiwanese manufacturer Vegefarm for Asian market expansion. The company also acquired Twine Solutions in 2025 to expand its digital printing capabilities.

The company's strategic moat rests on its patented bioprinting processes and a B2B licensing model that reduces capital barriers for partners. However, the cultivated meat sector faces regulatory hurdles in multiple markets and high production costs relative to conventional meat. Steakholder Foods achieved first revenue in 2024 and reduced losses by 45%, but its Nasdaq-listed stock (STKH) and reliance on continued funding—including a $1.25M securities purchase agreement and an $8M equity line of credit through 2026—highlight the capital-intensive nature of scaling bioprinted meat production.